These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 21853991

  • 1. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
    Ma L, Chen J, Wang X, Liang X, Luo Y, Zhu W, Wang T, Peng M, Li S, Jie S, Peng A, Wei Y, Chen L.
    J Med Chem; 2011 Oct 13; 54(19):6469-81. PubMed ID: 21853991
    [Abstract] [Full Text] [Related]

  • 2. Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol.
    Luo Y, Xu Y, Chen L, Hu J, Peng C, Xie D, Shi J, Huang W, Xu G, Peng M, Han J, Li R, Yang S, Wei Y.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4702-5. PubMed ID: 19589678
    [Abstract] [Full Text] [Related]

  • 3. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
    Tran TC, Sneed B, Haider J, Blavo D, White A, Aiyejorun T, Baranowski TC, Rubinstein AL, Doan TN, Dingledine R, Sandberg EM.
    Cancer Res; 2007 Dec 01; 67(23):11386-92. PubMed ID: 18056466
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis, and anti-proliferative evaluation of [1,1'-biphenyl]-4-ols as inhibitor of HUVEC migration and tube formation.
    Ran Y, Ma L, Wang X, Chen J, Wang G, Peng A, Chen L.
    Molecules; 2012 Jul 05; 17(7):8091-104. PubMed ID: 22766801
    [Abstract] [Full Text] [Related]

  • 5. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
    Tang H, Zhang Y, Li D, Fu S, Tang M, Wan L, Chen K, Liu Z, Xue L, Peng A, Ye H, Chen L.
    Eur J Med Chem; 2018 Aug 05; 156():190-205. PubMed ID: 30006164
    [Abstract] [Full Text] [Related]

  • 6. Structural modification of an angiogenesis inhibitor discovered from traditional Chinese medicine and a structure-activity relationship study.
    Yang SP, Cai YJ, Zhang BL, Tong LJ, Xie H, Wu Y, Lin LP, Ding J, Yue JM.
    J Med Chem; 2008 Jan 10; 51(1):77-85. PubMed ID: 18078313
    [Abstract] [Full Text] [Related]

  • 7. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Hou W, Chen L, Yang G, Zhou H, Jiang Q, Zhong Z, Hu J, Chen X, Wang X, Yuan Y, Tang M, Wen J, Wei Y.
    Phytother Res; 2008 Aug 10; 22(8):1125-32. PubMed ID: 18570244
    [Abstract] [Full Text] [Related]

  • 8. Formylated honokiol analogs showed antitumor activity against lung carcinoma.
    Deng S, Zhang C, Yang L, Ma L.
    Anticancer Drugs; 2019 Sep 10; 30(8):795-802. PubMed ID: 30807551
    [Abstract] [Full Text] [Related]

  • 9. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
    Singh T, Katiyar SK.
    Int J Oncol; 2011 Mar 10; 38(3):769-76. PubMed ID: 21225228
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (HSP90) inhibitors targeting proliferation and angiogenesis.
    Chang DJ, An H, Kim KS, Kim HH, Jung J, Lee JM, Kim NJ, Han YT, Yun H, Lee S, Lee G, Lee S, Lee JS, Cha JH, Park JH, Park JW, Lee SC, Kim SG, Kim JH, Lee HY, Kim KW, Suh YG.
    J Med Chem; 2012 Dec 27; 55(24):10863-84. PubMed ID: 23186287
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and microbiological evaluation of honokiol derivatives as new antimicrobial agents.
    Kim YS, Lee JY, Park J, Hwang W, Lee J, Park D.
    Arch Pharm Res; 2010 Jan 27; 33(1):61-5. PubMed ID: 20191344
    [Abstract] [Full Text] [Related]

  • 12. 5-Formylhonokiol exerts anti-angiogenesis activity via inactivating the ERK signaling pathway.
    Zhu W, Fu A, Hu J, Wang T, Luo Y, Peng M, Ma Y, Wei Y, Chen L.
    Exp Mol Med; 2011 Mar 31; 43(3):146-52. PubMed ID: 21297378
    [Abstract] [Full Text] [Related]

  • 13. Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells.
    Ou HC, Chou FP, Lin TM, Yang CH, Sheu WH.
    Chem Biol Interact; 2006 May 15; 161(1):1-13. PubMed ID: 16580656
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.
    Wang G, Wang F, Cao D, Liu Y, Zhang R, Ye H, Li X, He L, Yang Z, Ma L, Peng A, Xiang M, Wei Y, Chen L.
    Bioorg Med Chem Lett; 2014 Jul 15; 24(14):3158-63. PubMed ID: 24863745
    [Abstract] [Full Text] [Related]

  • 15. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
    Li Z, Liu Y, Zhao X, Pan X, Yin R, Huang C, Chen L, Wei Y.
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep 15; 140(1):95-102. PubMed ID: 18440692
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and antiangiogenic activity of novel gambogic acid derivatives.
    Chen T, Zhang RH, He SC, Xu QY, Ma L, Wang GC, Qiu N, Peng F, Chen JY, Qiu JX, Peng AH, Chen LJ.
    Molecules; 2012 May 25; 17(6):6249-68. PubMed ID: 22634837
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases.
    Vavilala DT, Ponnaluri VK, Kanjilal D, Mukherji M.
    PLoS One; 2014 May 25; 9(11):e113717. PubMed ID: 25422886
    [Abstract] [Full Text] [Related]

  • 18. Antiangiogenic activity of Diallyl Sulfide (DAS).
    Thejass P, Kuttan G.
    Int Immunopharmacol; 2007 Mar 25; 7(3):295-305. PubMed ID: 17276887
    [Abstract] [Full Text] [Related]

  • 19. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment.
    Seng WL, Eng K, Lee J, McGrath P.
    Angiogenesis; 2004 Mar 25; 7(3):243-53. PubMed ID: 15609079
    [Abstract] [Full Text] [Related]

  • 20. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kühnl A, Schulz CO, Elstner E, Possinger K, Eucker J.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):43-51. PubMed ID: 18588872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.